MindBio Hires Senergy Communications Capital

(via TheNewswire)

Vancouver, British Columbia – TheNewswire - December 15, 2025 – MindBio Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6), (the “Company” or “MindBio”), a biotechnology company that conducts clinical health research and has developed prediction tools for drug and alcohol intoxication detection, is pleased to announce it has engaged Senergy Communications Capital Inc. ("Senergy") to provide marketing and investor awareness services.

Senergy is an arm's-length marketing, advertising and shareholder relations firm based in Vancouver, Canada.  Senergy will design and execute comprehensive campaigns that include corporate branding, social media, and targeted e-mail marketing and online advertising and advertorial initiatives.  Under the terms of the engagement, the Company will pay Senergy CAD$150,000, to cover service fees and advertising expenses, in advance for an initial three-month term commencing on January 5, 2026, with the option to renew.  To the Company’s knowledge, neither Senergy, not its principal Aleem Fidai, own any securities of the Company.  Senergy can be contacted at:

Senergy Communications Capital Inc.

Contact: Aleem Fidai

Address: 1122 Mainland St., Suite 228, Vancouver, B.C., V6B 5L1

E-mail: [email protected]

Phone: 778-772-6740

For further information, please contact:

Justin Hanka, Chief Executive Officer

61 433140886

[email protected]

About MindBio Therapeutics

MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6) is a clinical-stage biotechnology company headquartered in Vancouver, British Columbia, that for several years has been conducting clinical trials and is focused on developing novel treatments for mental health disorders and health prediction technologies using AI and machine learning.  The Company has expertise in developing speech analytics as a prediction tool for drug and alcohol intoxication.

Cautionary Note Concerning Forward-Looking Statements:

The press release contains "forward-looking statements" within the meaning of applicable securities laws. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "budget," "believe," "project," "estimate," "expect," "scheduled," "forecast," "strategy," "future," "likely," "may," "to be," "could," "would," "should," "will" and similar references to future periods or the negative or comparable terminology, as well as terms usually used in the future and conditional. Forward-looking statements are based on assumptions as of the date they are provided. However, there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.

Additionally, there are known and unknown risk factors that could cause the Company's actual results and financial conditions to differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important risk factors that could cause actual results and financial conditions to differ materially from those indicated in the forward-looking statements, include among others: general economic, market and business conditions in Canada and Australia; market volatility; unforeseen delays in timelines for any of the transactions or events described in this press release.  All forward-looking information is qualified in its entirety by this cautionary statement.

The Company disclaims any obligation to revise or update any such forward-looking statement or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.

Neither the Canadian Securities Exchange nor its Regulation Service Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Copyright (c) 2025 TheNewswire - All rights reserved.